22 January 2022 : Clinical Research
A Questionnaire-Based Study to Obtain a Consensus from 5 Polish Burns Centers on Eschar Removal by Bromelain-Based Enzymatic Debridement (Nexobrid®) in Burns Following the 2020 Updated European Consensus Guidelines
Tomasz Korzeniowski12ABCDEFG*, Jerzy Strużyna13ACDEFG, Anna M. Chrapusta4ABCDE, Andrzej Krajewski5ABDE, Marek Kucharzewski6ABDEF, Krzysztof Piorun
5ABCE, Jakub Nowakowski7BCDF, Agnieszka Surowiecka1ACDE, Magdalena Kozicka12ABDF, Kamil Torres12BDEG
DOI: 10.12659/MSM.935632
Med Sci Monit 2022; 28:e935632
Table 5 Consensus statements and agreement on early and long-term outcomes after enzymatic debridement.
| s | Statement | Agreement | Likert scale | Consensus |
|---|---|---|---|---|
| 22 | Given its selective effect, enzymatic debridement allows preservation of live dermis more effectively than standard procedures | 100% | 4/5 strongly agree1/5 agree | Yes |
| 23 | Extended conservative treatment after enzymatic debridement may impair the healing process and result in a poorer outcome (hypertrophied scars), which is why additional debridement procedures and skin grafting need to be considered on a regular basis | 100% | 4/5 strongly agree1/5 agree | Yes |
| 24 | Scar treatment after enzymatic debridement needs to follow standard burn care protocols | 100% | 5/5 strongly agree | Yes |